๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

UR-3216: A Manageable Oral GPIIb/IIIa Antagonist

โœ Scribed by Baba, Kosuke ;Aga, Yasuhiro ;Nakanishi, Takayuki ;Motoyama, Takahiro ;Ueno, Hitoshi


Book ID
109106049
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
207 KB
Volume
19
Category
Article
ISSN
0897-5957

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Orbofiban: An orally active GPIIb/IIIa p
โœ Nancy S. Nicholson; Norman A. Abood; Susan G. Panzer-Knodle; Leo G. Frederick; J ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 438 KB

## Abstract A key role has been established for platelet activation and thrombus formation in the pathogenesis of acute coronary syndromes, and restenosis after percutaneous interventions. Antiplatelet agents that have a wider spectrum of activity than aspirin, and clopidogrel would be expected to

ChemInform Abstract: Isoxazoline GPIIb/I
โœ John Wityak; A. Ewa Tobin; Shaker A. Mousa; Ruth R. Wexler; Richard E. Olson ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons โš– 27 KB

Isoxazoline GPIIb/IIIa Antagonists Bearing a Phosphoramidate -[synthesis and in vitro antiplatelet efficacy of a series of novel phosphoramidates (I) (6 examples)]. -(WITYAK, JOHN;